Apolipoprotein A5 and Hypertriglyceridemia (Editorials) Apolipoprotein A5 and Hypertriglyceridemia (Editorials)

Apolipoprotein A5 and Hypertriglyceridemia (Editorials‪)‬

Clinical Chemistry, 2005, Feb, 51, 2

Clinical Chemistry
    • €2.99
    • €2.99

Publisher Description

Hypertriglyceridemia is associated with increased risk of coronary heart disease (CHD) (1-5), and it is an integral component of the overlapping syndromes of familial combined hyperlipidemia, insulin resistance syndrome, atherogenic lipoprotein profile, and hyperapobetali-poproteinemia (6). More than one mechanism may be involved in the increased risk of CHD associated with increased serum triglycerides: * Triglyceride-rich lipoproteins (TGRLs) may participate directly in atherogenesis, particularly when they have undergone attack by oxygen free radicals (7).

GENRE
Science & Nature
RELEASED
2005
1 February
LANGUAGE
EN
English
LENGTH
9
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SIZE
159.8
KB

More Books Like This

High-Density Lipoproteins High-Density Lipoproteins
High-Density Lipoproteins
2011
Apolipoprotein C-III Bound to Apolipoprotein B-Containing Lipoproteins in Obese Girls (Technical Briefs) Apolipoprotein C-III Bound to Apolipoprotein B-Containing Lipoproteins in Obese Girls (Technical Briefs)
Apolipoprotein C-III Bound to Apolipoprotein B-Containing Lipoproteins in Obese Girls (Technical Briefs)
2003
The HDL Handbook The HDL Handbook
The HDL Handbook
2017
Association Between Genetic Variations of Apo AI-CIII-AIV Cluster Gene and Hypertriglyceridemic Subjects (Molecular Pathology and Genetics) Association Between Genetic Variations of Apo AI-CIII-AIV Cluster Gene and Hypertriglyceridemic Subjects (Molecular Pathology and Genetics)
Association Between Genetic Variations of Apo AI-CIII-AIV Cluster Gene and Hypertriglyceridemic Subjects (Molecular Pathology and Genetics)
1997
Evolving Lipoprotein Risk Factors: Lipoprotein(A) and Oxidized Low-Density Lipoprotein (Beckman Conference) Evolving Lipoprotein Risk Factors: Lipoprotein(A) and Oxidized Low-Density Lipoprotein (Beckman Conference)
Evolving Lipoprotein Risk Factors: Lipoprotein(A) and Oxidized Low-Density Lipoprotein (Beckman Conference)
1998
Lipoproteins as Carriers of Pharmacological Agents Lipoproteins as Carriers of Pharmacological Agents
Lipoproteins as Carriers of Pharmacological Agents
2017

More Books by Clinical Chemistry

Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report) Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report)
Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report)
2002
DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs) DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs)
DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs)
2004
Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs) Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs)
Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs)
2003
High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial) High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial)
High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial)
2008
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs) Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs)
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs)
2005
D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report) D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report)
D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report)
2004